The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per The Business Research Company’s Preclinical Imaging Global Market Report 2023, the preclinical imaging market is expected to show significant growth in the forecast period.

Key insights from the preclinical imaging market forecast include:

1. Market Size

The worldwide preclinical imaging market is anticipated to rise from $2.98 billion in 2022 to $3.20 billion in 2023, with a 7.5% compound annual growth rate (CAGR). The preclinical imaging market is projected to achieve $4.13 billion in 2027 at a 6.5% CAGR.

2. Major Driver

The surge in chronic illnesses is poised to drive the preclinical imaging market’s expansion. Chronic diseases are persistent health conditions that endure for an extended period, typically exceeding three months. For example, in September 2022, the World Health Organization (WHO) highlighted that out of 41 million annual global deaths, 74% are attributed to non-communicable diseases (NCDs) or chronic diseases. These NCDs encompass 17.9 million fatalities from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Consequently, the increasing prevalence of chronic diseases fuels the preclinical imaging market’s growth.

View More On The Preclinical Imaging Market Report 2023 – https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

3. Key Trend

In the preclinical imaging market, a prominent trend is the proliferation of product innovations. Leading companies within this market are actively engaged in the development of inventive products to maintain their market standing. A notable instance of this trend is the May 2022 introduction of the Vevo F2 by Fujifilm VisualSonics Inc., a Canadian biomedical firm specializing in imaging systems. The Vevo F2 represents the world’s initial ultra-high-to-low-frequency (ranging from 71 MHz to 1 MHz) ultrasonic and photoacoustic imaging system designed for preclinical applications. Distinguished by its utilization of high-definition image processing technology and a revamped signal pathway, the system elevates image clarity and frame rates. Furthermore, it is adaptable to accommodate the specific precision requirements of diverse imaging needs. The system offers a wide array of features, including customizable system architecture, suitability for imaging various anatomical targets, and high-resolution imaging capabilities, rendering it versatile for a range of research applications. The Vevo F2 has garnered praise for its adaptability and its capacity for high-quality imaging.

4. Largest Region

North America was the largest region in the preclinical imaging market in 2022.

5. Major Players

Major players in the preclinical imaging market are Thermo Fisher Scientific Inc., FUJIFILM Visualsonics Inc., Konica Minolta Inc., Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc., Promega Corporation, Ion Beam Applications S.A, Nihon Kohden, EKF Diagnostics Holdings plc., Piramal Enterprises Ltd, LI-COR Biosciences Inc., Aspect Imaging Ltd, Capintec Inc., Spectral Instruments Inc., Mediso Ltd, MR Solutions Ltd, Biospace Lab S. A., Scintica Instrumentation Inc., Trifoil Imaging, Bioscan Inc., CytoSMART Technologies B.V, Inviscan SAS, Kubtec X-ray, MILabs B.V., SCANCO Medical AG, and Cristal Therapeutics.

Request A Sample Of The Global Preclinical Imaging Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12393&type=smp

Key Preclinical Imaging Market Segments
The global preclinical imaging market is segmented –
1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems
2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents
3) By End User: Hospital, Diagnostics Center, Other End-User

The Preclinical Imaging Global Market Report 2023  provides an in-depth analysis on the preclinical imaging market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the preclinical imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
3D Medical Imaging Devices Global Market Report 2023
3D Diagnostic Imaging Services Global Market Report 2023
Intraoperative Imaging Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model